Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin therapy for prevention of composite vascular events after acute cardioembolic stroke without definite statin indication
KCT0006806Phase 4Recruiting
- Sponsor
- Dong-A ST
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin in ischemic stroke and myocardial infarction (MI) (2 arms), sponsored by Dong-A ST. Primary endpoint: Composite event outcome. Started Jan 2023; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
ischemic strokemyocardial infarction (MI)
Beyond the preview
Go deeper on KCT0006806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006806.